ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Cincinnati, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Endometrial Cancer
Squamous Cell Carcinoma of Head and Neck
Non-Small-Cell Lung Carcinoma
Ovarian Cancer

Breast Cancer trials near Cincinnati, OH, USA:

DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]

This study will compare DS 8201a to standard treatment.Participants must have HER2 breast cancer that has been treated before.Their ...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab
Drug: Trastuzumab deruxtecan

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Cincinnati, Ohio, United States and 226 other locations

postmenopausal women with locally advanced or metastatic ER+/HER2- breast cancer with an acquired ESR1 mutation and who have diseas...

Active, not recruiting
Locally Advanced or Metastatic Breast Cancer
Drug: Lasofoxifene
Drug: Fulvestrant

Phase 2

Sermonix Pharmaceuticals

Cincinnati, Ohio, United States and 50 other locations

for the treatment of participants with metastatic HER2-positive breast cancer who have progressed on, or are intolerant to, previou...

Enrolling
Metastatic HER2-positive Breast Cancer
Drug: Trastuzumab
Drug: Gemcitabine

Phase 3

Jazz Pharmaceuticals
Jazz Pharmaceuticals

Cincinnati, Ohio, United States of America and 9 other locations

body) and a treatment part. The primary purpose of the study is to see how (Z)-endoxifen works on tumor cell growth by monitoring a cancer...

Enrolling
Estrogen-receptor-positive Breast Cancer
Breast Neoplasms
Drug: exemestane
Drug: goserelin

Phase 2

Atossa Therapeutics

Edgewood, Kentucky, United States and 9 other locations

how treatment with Fulvestrant (FASLODEX) or Anastrozole (ARIMIDEX) effects disease progression for women with locally advanced or metastatic breast...

Active, not recruiting
Hormone Receptor Positive Breast Cancer
Drug: faslodex dummy
Drug: arimidex dummy

Phase 3

AstraZeneca
AstraZeneca

Montgomery, Ohio, United States and 118 other locations

with anti-HER2 antibodies in patients with HER2-negative invasive breast cancer who have abnormal HER2 signaling activity determine...

Enrolling
HER2-negative Breast Cancer
Drug: Doxorubicin
Drug: Cyclophosphamide

Phase 2

National Surgical Adjuvant Breast and Bowel Project Foundation (NSABP)

Dayton, Ohio, United States of America and 42 other locations

This study is designed to compare the anti-tumor activity as well as the safety and efficacy of DS-8201a versus T-DM1 in HER2-positive, unre ...

Active, not recruiting
Breast Cancer
Drug: Trastuzumab deruxtecan (T-DXd)
Drug: Ado-trastuzumab emtansine (T-DM1)

Phase 3

Daiichi Sankyo
Daiichi Sankyo

Cincinnati, Ohio, United States and 163 other locations

of tumor and/or stromal area of infiltrating lymphocytes prior to initiation of standard neoadjuvant chemotherapy. At enrollment, patients ...

Active, not recruiting
Stage IIIA Breast Cancer
Estrogen Receptor-positive Breast Cancer
Drug: Paclitaxel
Drug: Cyclophosphamide

Phase 2

Virginia Commonwealth University (VCU)
Virginia Commonwealth University (VCU)

Edgewood, Kentucky, United States and 4 other locations

of fulvestrant or an aromatase inhibitor in women and men with breast cancer whose disease has advanced on one endocrine therapy in...

Enrolling
Breast Cancer
ER Positive Breast Cancer
Drug: Letrozole
Drug: Exemestane

Phase 3

Olema Pharmaceuticals

Dayton, Ohio, United States and 173 other locations

RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer...

Active, not recruiting
Breast Cancer
Other: Placebo
Drug: Letrozole

Phase 3

National Surgical Adjuvant Breast and Bowel Project Foundation (NSABP)

Cincinnati, Ohio, United States and 805 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems